| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 26 | 16 | 19 | 17 | 19 | 22 | 25 | 27 | 22 | 23 | 36 | 25 | 23 | 23 | 43 | 24 | 21 | 21 | 26 | 26 | 24 | 18 | 27 | 25 | 21 | 29 | 36 | 51 | 48 | 37 | 43 | 47 | 41 | 49 | 43 | 51 | 47 | 50 | 49 | 40 |
| Expenses | 23 | 14 | 16 | 15 | 17 | 18 | 22 | 23 | 19 | 21 | 31 | 22 | 21 | 21 | 37 | 21 | 19 | 19 | 23 | 24 | 23 | 15 | 22 | 22 | 21 | 25 | 30 | 44 | 41 | 31 | 38 | 40 | 36 | 42 | 37 | 45 | 41 | 42 | 41 | 36 |
| EBITDA | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 2 | 2 | 5 | 3 | 1 | 3 | 6 | 2 | 1 | 2 | 3 | 1 | 1 | 3 | 5 | 3 | -0 | 3 | 6 | 7 | 7 | 5 | 6 | 7 | 5 | 7 | 6 | 6 | 6 | 9 | 8 | 5 |
| Operating Profit % | 10 % | 17 % | 17 % | 14 % | 8 % | 15 % | 13 % | 14 % | 10 % | 9 % | 13 % | 11 % | 2 % | 11 % | 12 % | 8 % | 4 % | 10 % | 11 % | 5 % | 2 % | 15 % | 18 % | 11 % | -2 % | 12 % | 16 % | 14 % | 15 % | 14 % | 13 % | 16 % | 12 % | 13 % | 12 % | 12 % | 13 % | 17 % | 15 % | 11 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| Profit Before Tax | 1 | 1 | 2 | 1 | 0 | 2 | 1 | 2 | 0 | 0 | 3 | 1 | -1 | 1 | 4 | 0 | -1 | 0 | 0 | -1 | -2 | 0 | 2 | 0 | -3 | 1 | 3 | 5 | 4 | 3 | 3 | 4 | 2 | 4 | 2 | 3 | 3 | 5 | 5 | 2 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 0 | 2 | 1 | 2 | 0 | 0 | 3 | 1 | -1 | 1 | 4 | 0 | -1 | 0 | 0 | -1 | -3 | 0 | 2 | 0 | -3 | 1 | 3 | 5 | -0 | 2 | 2 | 3 | 1 | 3 | 2 | 2 | 2 | 4 | 3 | 1 |
| EPS in ₹ | 1.29 | 1.00 | 1.65 | 0.99 | 0.31 | 1.88 | 1.27 | 1.91 | 0.35 | 0.18 | 3.43 | 0.75 | -0.82 | 0.85 | 4.89 | 0.46 | -0.82 | 0.09 | 0.42 | -0.97 | -3.02 | 0.27 | 2.82 | 0.14 | -3.65 | 1.15 | 3.38 | 5.37 | -0.18 | 1.97 | 1.83 | 2.96 | 1.30 | 2.90 | 1.63 | 1.90 | 1.95 | 3.47 | 2.97 | 1.06 |
Parnax Lab
102.00
+2.74
(2.76%)
Market Cap
117.15 Cr
EPS
8.38
PE Ratio
10.51
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
193.50
52 Week Low
81.00
PB Ratio
1.44
Debt to Equity
1.01
Sector
Pharmaceuticals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,764.75 | 4,23,422.64 | 36.32 | 49,887.20 | 12.06 | 9,648 | 13.77 | 61.58 | |
| 5,840.65 | 1,55,050.91 | 75.90 | 8,184.00 | 0.89 | 1,600 | 64.53 | 55.23 | |
| 1,511.20 | 1,22,046.63 | 24.67 | 26,520.70 | 14.17 | 4,155 | 47.38 | 60.28 | |
| 3,245.05 | 1,09,827.24 | 59.25 | 10,785.70 | 11.59 | 1,656 | 13.54 | 61.68 | |
| 2,398.05 | 98,935.61 | 47.95 | 10,615.60 | 19.57 | 1,942 | -16.38 | 56.07 | |
| 1,177.90 | 98,285.26 | 18.80 | 28,905.40 | 12.36 | 5,578 | 1.69 | 51.86 | |
| 2,068.75 | 94,375.87 | 33.76 | 20,141.50 | 19.94 | 1,936 | 38.82 | 54.50 | |
| 907.35 | 91,300.64 | 20.56 | 19,831.50 | 13.82 | 3,831 | 29.92 | 48.54 | |
| 1,194.95 | 69,402.89 | 19.93 | 29,559.20 | 17.55 | 3,169 | -10.04 | 61.05 | |
| 31,101.85 | 66,089.26 | 49.48 | 6,097.20 | 10.80 | 1,201 | 16.01 | 61.04 |
Growth Rate
Revenue Growth
12.53 %
Net Income Growth
11.63 %
Cash Flow Change
-24.06 %
ROE
-3.24 %
ROCE
-22.56 %
EBITDA Margin (Avg.)
-8.93 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 83 | 79 | 86 | 87 | 95 | 107 | 106 | 154 | 145 | 189 |
| Fixed Assets | 36 | 38 | 47 | 44 | 51 | 58 | 60 | 72 | 77 | 90 |
| Current Assets | 38 | 31 | 31 | 37 | 37 | 46 | 39 | 71 | 57 | 72 |
| Capital Work in Progress | 1 | 2 | 0 | 0 | 0 | 3 | 5 | 3 | 2 | 21 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 46 | 39 | 38 | 43 | 43 | 46 | 42 | 78 | 66 | 79 |
| Total Liabilities | 83 | 79 | 86 | 87 | 95 | 107 | 106 | 154 | 145 | 189 |
| Current Liabilities | 31 | 29 | 36 | 37 | 36 | 53 | 54 | 81 | 63 | 82 |
| Non Current Liabilities | 27 | 23 | 18 | 18 | 23 | 22 | 19 | 24 | 20 | 35 |
| Total Equity | 25 | 28 | 31 | 33 | 36 | 33 | 33 | 48 | 62 | 72 |
| Reserve & Surplus | 17 | 19 | 23 | 24 | 27 | 24 | 24 | 37 | 51 | 60 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 12 | 12 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 2 | -2 | 0 | 1 | -1 | 0 | -0 | 4 | -3 | -1 |
| Investing Activities | -4 | -6 | -10 | -5 | -11 | -13 | -7 | -17 | -10 | -32 |
| Operating Activities | -0 | 4 | 16 | 13 | 9 | 9 | 6 | 9 | 21 | 16 |
| Financing Activities | 6 | 1 | -5 | -7 | 1 | 5 | 0 | 12 | -14 | 15 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Apr 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 62.59 % | 62.59 % | 62.59 % | 62.59 % | 67.58 % | 67.58 % | 67.58 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.46 % | 33.99 % | 33.31 % | 33.30 % | 29.07 % | 29.07 % | 28.30 % | 23.90 % | 23.83 % | 24.59 % | 24.86 % | 24.88 % | 24.46 % | 24.45 % | 24.60 % | 24.26 % | 24.68 % |
| Others | 3.95 % | 3.42 % | 4.10 % | 4.11 % | 3.35 % | 3.35 % | 4.12 % | 3.80 % | 3.88 % | 3.11 % | 2.84 % | 2.83 % | 3.25 % | 3.26 % | 3.11 % | 3.44 % | 3.02 % |
| No of Share Holders | 2,105 | 2,207 | 2,139 | 2,259 | 2,403 | 2,403 | 2,605 | 3,096 | 3,070 | 3,060 | 3,221 | 3,543 | 3,536 | 4,496 | 4,406 | 4,173 | 4,521 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Closure of Trading Window
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Announcement under Regulation 30 (LODR)-Change in Management
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Announcement under Regulation 30 (LODR)-Newspaper Publication
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Integrated Filing (Financial)
Announcement under Regulation 30 (LODR)-Change in Management
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024.
Board Meeting Outcome for Board Meeting Outcome For The BM Dated 10.02.2025
Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q3) And Nine Mon
Announcement Under Regulation 30 W.R.T. Intimation Of Change In Name Of Registrar And Transfer Agent (RTA) Of Parnax Lab Limited (Company).
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Change in Management
Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Along With Limited Review Report For The Quarter (Q2) And Half Year Ended 30Th September, 2024.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Announcement under Regulation 30 (LODR)-Newspaper Publication
Reg. 34 (1) Annual Report.
Notice Of 42Nd Annual General Meeting Schedule To Be Held On Friday, 27Th September, 2024.
Corporate Action- Fixes Book Closure For Annual General Meeting
Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial Results For The Quarter And Three Months Ended June, 2024
Board Meeting Outcome for Board Meeting Outcome
Board Meeting Intimation for 1. Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q1) And Three Months Ended 30Th June, 2024.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR)-Resignation of Director
Announcement under Regulation 30 (LODR)-Change in Management
Shareholder Meeting / Postal Ballot-Scrutinizers Report
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Closure of Trading Window
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Announcement under Regulation 30 (LODR)-Newspaper Publication
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Compliances-Reg.24(A)-Annual Secretarial Compliance
Results-Audited Financial Results For The Quarter And Year Ended March 31, 2024.
Board Meeting Outcome for Board Meeting Outcome For Results-Audited Financial Results For The Quarter And Year Ended March 31, 2024.
Board Meeting Intimation for Board Meeting Intimation For The Meeting To Be Held On Thursday, May 30, 2024.
Certificate As Per Regulation 40(9) Of The Listing Obligations And Disclosure Requirement Regulation, 2015 For The Year Ended 31St March, 2024.
Compliance Certificate For The Period Ended March 31, 2024.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR)-Retirement
Closure of Trading Window
Results-Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023
Board Meeting Outcome for Results-Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023
Technical Indicators
RSI(14)
Neutral 48.12
ATR(14)
Less Volatile 7.35
STOCH(9,6)
Neutral 70.98
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 3.22
ADX(14)
Strong Trend 42.97
UO(9)
Bearish 43.30
ROC(12)
Uptrend And Accelerating 11.52
WillR(14)
Neutral -25.36
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
